Cancel
About Niv Caner
Niv Caner is a Senior Software Engineer with extensive involvement in veterinary oncology, particularly in developing novel immunotherapies for brain tumors in dogs and exploring the role of genomics in cancer diagnostics and treatment.
Known information
Niv Caner, a Senior Software Engineer, has significantly contributed to the field of veterinary oncology. Caner has participated in discussions with key figures such as Dr. Len Lichtenfeld, former Deputy Chief Medical Officer of the American Cancer Society, and Dr. Gerry Post of FidoCure, focusing on an 8-year journey in cancer research affecting both humans and animals. Caner’s work includes comparative aging research intersecting with cancer and musculoskeletal studies in veterinary medicine. A notable area of Caner’s expertise is the development of novel immunotherapies for brain tumors in pet dogs, a topic explored with Dr. Neal Mauldin of PetCure Oncology. Additionally, Caner has discussed the critical role of genomics in veterinary oncology, which aids in making more precise diagnoses and prognoses. Caner’s insights also extend to combination therapy approaches for treating canine cancer, highlighting a forward-looking perspective in veterinary medical treatments.
About FidoCure®
FidoCure®, formerly known as The One Health Company, is a healthcare firm based in Palo Alto, CA, specializing in personalized medicine and genomic testing for canine cancer treatment.
Report inaccurate information
